Genetic programming for human oral bioavailability of drugs

GECCO 2006 - Genetic and Evolutionary Computation Conference

Volumn 1, Issue , 2006, Pages 255-262

  Archetti, Francesco ^a   Lanzeni, Stefano ^a   Messina, Enza ^a   Vanneschi, Leonardo ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Bioavailability; Bioinformatics; Genetic Programming; Molecular Descriptors

Indexed keywords

DATA STRUCTURES; GENETIC ALGORITHMS; LEARNING SYSTEMS; METHOD OF MOMENTS; PHARMACODYNAMICS;

BIOAVAILABILITY; BIOINFORMATICS; GENETIC PROGRAMMING; MOLECULAR DESCRIPTORS;

DRUG PRODUCTS;

EID: 33750254294     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1145/1143997.1144042     Document Type: Conference Paper

References (29)

1. Accelrys Inc., the world leader in cheminformatics for drug development. See www.accelrys.com.
2. Andrews, C. W., Bennett, L. & Yu, L. X. Predicting human oral bioavailability of a compound: development of a novel quantitative structure-bioavailability relationship. Pharm. Res. 17, 639-644 (2000).
3. Akaike, H., 2nd International Symposium on Information Theory, Chapter Information theory and an extension of maximum likelihood principle, pp. 267-281, 1973. Akademia Kiado.
4. Bains W, Gilbert R, Sriridenko L et al., Evolutionary computational methods to predict oral bioavailability QSPRs, Curr Opin Drug Discov. Devel., 2002, Jan 5(1):44-51.
5. Cagnoni S., D. Rivero and L. Vanneschi. A purely-evolutionary memetic algorithm as a first step towards symbiotic convolution. In Proceedings of the 2005 IEEE Congress on Evolutionary Computation (CEC 2005), pages 1156-1163, Edinburgh, Scotland, 2005. IEEE Press, Piscataway, NJ.
6. Chemical Information Systems Inc., the company that introduced SMILES molecule representation. See http://www.daylight.com/dayhtml/smiles.
7. Drug Bank, a recently developed database of PDA approved and experimental drugs. See http://redpoll.pharmacy.ualberta.ca/drugbank/.
8. Fröhlich, J. Wegner, F. Sieker, A. Zell: Kernel Functions for Attributed Molecular Graphs - A New Similarity Based Approach To ADME Prediction in Classification and Regression, QSAR & Combinatorial Science, 2005.
9. Hall, M. A. 1998. Correlation-based Feature Selection for Machine Learning. Ph.D diss. Hamilton, NZ: Waikato University, Department of Computer Science.
10. Haykin S., Neural Networks: a comprehensive foundation. Prentice Hall, London, UK, 1999.
11. I.T. Jolliffe, Principal Component Analysis, Second edition, Springer series in statistics.
12. Keijzer M., Improving symbolic regression with interval arithmetic and linear scaling. In C. Ryan et al. editors, Genetic Programming, Proceedings of the 6th European Conference, EuroGP 2003, volume 2610, of LNCS, pages 71-83, Essex, 2003. Springer, Berlin, Heidelberg, New York.
13. Kennedy, T. Managing the drug discovery development interface. Drug Disc. Today 2, 436-444 (1997).
14. Koza J.R. Genetic Programming. The MIT Press, Cambridge, Massachusetts, 1992.
15. Langdon W. B. and S. J. Barrett, Genetic Programming in data mining for drug discovery, in Evolutionary computing in data mining, p. 211-235,2004 Springer.
16. Lipinsky et al., Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev., 23:3-25, (1997)
17. Pharma Algorithms, a company active in the field of ADMET predictions. See www.ap-algorithms.com.
18. Pintore, M., Van de Waterbeemd, H., Piclin, N. & Chrétien, J. R., Prediction of oral bioavailability by adaptive fuzzy partitioning, Eur. J. Med. Chem. 2003, Apr;38(4):427-31.
19. Rousseeuw, Peter J, Robust regression and outlier detection / Peter J. Rousseeuw, Annick M. Leroy, New York : Wiley, 1987.
20. Simulation Plus Inc., company that use both statistical methods and differential equations based simulations for ADME parameter estimation, www.simulationsplus.com.
21. Smola Alex J., Bernhard Scholkopf (1998). A Tutorial on Support Vector Regression. NeuroCOLT2 Technical Report Series - NC2-TR-1998-030.
22. Todeschini, R. & Consonni, V. Handbook of Molecular Descriptors (Wiley-VCH, Weinheim, 2000).
23. Topchy A. and W. F. Punch. Faster genetic programming based on local gradient search of numeric leaf values. In L. Spector et al. editors, Proceedings of the Genetic and Evolutionary Computation Conference, GECCO 2001, pages 155-162. San Francisco, CA, 2001. Morgan Kaufmann.
24. Van de Waterbeemd H. and Eric Gifford, ADMET in silico modeling: towards prediction paradise? Nature Reviews Drug Discovery, MARCH 2003, Vol. 2.
25. Van de Waterbeemd, H. & Rose, S. In The Practice of Medicinal Chemistry 2nd (ed Wermuth, L. G.) 1367-1385(Academic Press, 2003).
26. Veber, D. F., Johnson, S. R., Cheng, H. Y., Smith, B. R., Ward, K. W. & Kopple, K. D. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 45, 2615-2623 (2002).
27. Weka, a multi-task machine learning software developed by Waikato University. See www.cs.waikato.ac.nz/ml/weka/.
28. Yoshida, F. & Topliss, J. G. QSAR model for drug human oral bioavailability, J. Med. Chem. 43, 2575-2585 (2000).
29. nd edition, Wiley 1999.